New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
about
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma.Lingual metastasis as an initial presentation of renal cell carcinoma: a case report.MicroRNAs in cancer metastasis and angiogenesis.Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
P2860
Q38662419-2262D5CB-0DFD-4E77-9885-7E1FDCE489E7Q41573990-ADA30E59-D8F5-4C3E-8F5E-87E4C84FBCA3Q44631161-3D546E5F-7DDB-495D-A27F-4E21092F6AF1Q47703386-45CC9387-D351-4F87-BB31-3B5751BBDE45Q47813600-5EA7B673-5065-47E0-8800-8BDC22BBE9CAQ48226648-86F0512D-7D8A-498E-B8C9-9033DE4C681AQ50078523-89678226-5633-4E3F-BF4B-3FE690A57B94
P2860
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New treatment options for meta ...... rior anti-angiogenesis therapy
@en
New treatment options for meta ...... ior anti-angiogenesis therapy.
@nl
type
label
New treatment options for meta ...... rior anti-angiogenesis therapy
@en
New treatment options for meta ...... ior anti-angiogenesis therapy.
@nl
prefLabel
New treatment options for meta ...... rior anti-angiogenesis therapy
@en
New treatment options for meta ...... ior anti-angiogenesis therapy.
@nl
P2093
P2860
P921
P1476
New treatment options for meta ...... rior anti-angiogenesis therapy
@en
P2093
Chunhui Fang
Kevin Zarrabi
Shenhong Wu
P2860
P2888
P356
10.1186/S13045-016-0374-Y
P5008
P577
2017-02-02T00:00:00Z
P6179
1083412081